Information Provided By: 
Fly News Breaks for January 12, 2016
CELG
Jan 12, 2016 | 07:13 EDT
After Celgene preannounced lower than expected Q4 EPS and in-line revenue and the stock fell 5%, Wells Fargo says it was encouraged by the company's Q4 revenue and in-line REVLIMID sales. The firm thinks the company's guidance for 2016 and beyond was strong, and it believes the stock is "significantly undervalued."
News For CELG From the Last 2 Days
There are no results for your query CELG
